JP2020532951A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020532951A5 JP2020532951A5 JP2020504236A JP2020504236A JP2020532951A5 JP 2020532951 A5 JP2020532951 A5 JP 2020532951A5 JP 2020504236 A JP2020504236 A JP 2020504236A JP 2020504236 A JP2020504236 A JP 2020504236A JP 2020532951 A5 JP2020532951 A5 JP 2020532951A5
- Authority
- JP
- Japan
- Prior art keywords
- mir
- cells
- recombinant hsv
- item
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims description 102
- 244000309459 oncolytic virus Species 0.000 claims description 90
- 241000700584 Simplexvirus Species 0.000 claims description 85
- 108091070501 miRNA Proteins 0.000 claims description 57
- 108700005077 Viral Genes Proteins 0.000 claims description 52
- 108700011259 MicroRNAs Proteins 0.000 claims description 48
- 108090000623 proteins and genes Proteins 0.000 claims description 33
- 235000018102 proteins Nutrition 0.000 claims description 27
- 102000004169 proteins and genes Human genes 0.000 claims description 27
- 206010028980 Neoplasm Diseases 0.000 claims description 26
- -1 CCL4 Proteins 0.000 claims description 24
- 239000002679 microRNA Substances 0.000 claims description 24
- 101710130522 mRNA export factor Proteins 0.000 claims description 22
- 108091007780 MiR-122 Proteins 0.000 claims description 21
- 101150099321 UL42 gene Proteins 0.000 claims description 21
- 108091051828 miR-122 stem-loop Proteins 0.000 claims description 21
- 230000029812 viral genome replication Effects 0.000 claims description 21
- 108091044988 miR-125a stem-loop Proteins 0.000 claims description 20
- 108091049513 miR-125a-1 stem-loop Proteins 0.000 claims description 17
- 108091040046 miR-125a-2 stem-loop Proteins 0.000 claims description 17
- 241000700605 Viruses Species 0.000 claims description 16
- 108091033319 polynucleotide Proteins 0.000 claims description 16
- 102000040430 polynucleotide Human genes 0.000 claims description 16
- 239000002157 polynucleotide Substances 0.000 claims description 16
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 14
- 150000007523 nucleic acids Chemical group 0.000 claims description 14
- 230000010076 replication Effects 0.000 claims description 13
- 101150027427 ICP4 gene Proteins 0.000 claims description 12
- 101150033561 UL8 gene Proteins 0.000 claims description 12
- 201000011510 cancer Diseases 0.000 claims description 12
- 108091070636 miR-219a stem-loop Proteins 0.000 claims description 12
- 101100508081 Human herpesvirus 1 (strain 17) ICP34.5 gene Proteins 0.000 claims description 11
- 108091028066 Mir-126 Proteins 0.000 claims description 11
- 108091005804 Peptidases Proteins 0.000 claims description 11
- 239000004365 Protease Substances 0.000 claims description 11
- 101150027249 RL1 gene Proteins 0.000 claims description 11
- 108091028606 miR-1 stem-loop Proteins 0.000 claims description 11
- 102000013462 Interleukin-12 Human genes 0.000 claims description 9
- 108010065805 Interleukin-12 Proteins 0.000 claims description 9
- 102000035195 Peptidases Human genes 0.000 claims description 9
- 108091056924 miR-124 stem-loop Proteins 0.000 claims description 9
- 102100025248 C-X-C motif chemokine 10 Human genes 0.000 claims description 8
- 108091033409 CRISPR Proteins 0.000 claims description 8
- 101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 claims description 8
- 108091027966 Mir-137 Proteins 0.000 claims description 8
- 108091080995 Mir-9/mir-79 microRNA precursor family Proteins 0.000 claims description 8
- 108091031479 miR-204 stem-loop Proteins 0.000 claims description 8
- 108091032382 miR-204-1 stem-loop Proteins 0.000 claims description 8
- 108091085803 miR-204-2 stem-loop Proteins 0.000 claims description 8
- 108091089766 miR-204-3 stem-loop Proteins 0.000 claims description 8
- 108091073500 miR-204-4 stem-loop Proteins 0.000 claims description 8
- 108091053626 miR-204-5 stem-loop Proteins 0.000 claims description 8
- 108091047084 miR-9 stem-loop Proteins 0.000 claims description 8
- 101150026402 DBP gene Proteins 0.000 claims description 7
- 108091028684 Mir-145 Proteins 0.000 claims description 7
- 108091034117 Oligonucleotide Proteins 0.000 claims description 7
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 7
- 101150068034 UL30 gene Proteins 0.000 claims description 7
- 239000000427 antigen Substances 0.000 claims description 7
- 102000036639 antigens Human genes 0.000 claims description 7
- 108091007433 antigens Proteins 0.000 claims description 7
- 210000002064 heart cell Anatomy 0.000 claims description 7
- 108091070946 miR-128 stem-loop Proteins 0.000 claims description 7
- 108091079001 CRISPR RNA Proteins 0.000 claims description 6
- 238000010354 CRISPR gene editing Methods 0.000 claims description 6
- 108010042407 Endonucleases Proteins 0.000 claims description 6
- 101710163270 Nuclease Proteins 0.000 claims description 6
- 108091028113 Trans-activating crRNA Proteins 0.000 claims description 6
- 230000006698 induction Effects 0.000 claims description 6
- 108091047268 miR-208b stem-loop Proteins 0.000 claims description 6
- 108020005345 3' Untranslated Regions Proteins 0.000 claims description 5
- 101150064935 HELI gene Proteins 0.000 claims description 5
- 101100427508 Human cytomegalovirus (strain AD169) UL39 gene Proteins 0.000 claims description 5
- 101001042049 Human herpesvirus 1 (strain 17) Transcriptional regulator ICP22 Proteins 0.000 claims description 5
- 101000999690 Human herpesvirus 2 (strain HG52) E3 ubiquitin ligase ICP22 Proteins 0.000 claims description 5
- 108091026898 Leader sequence (mRNA) Proteins 0.000 claims description 5
- 101150093191 RIR1 gene Proteins 0.000 claims description 5
- 101150099617 UL5 gene Proteins 0.000 claims description 5
- 101150026859 UL9 gene Proteins 0.000 claims description 5
- 210000000663 muscle cell Anatomy 0.000 claims description 5
- 210000002569 neuron Anatomy 0.000 claims description 5
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 claims description 4
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 claims description 4
- 102000005600 Cathepsins Human genes 0.000 claims description 4
- 108010084457 Cathepsins Proteins 0.000 claims description 4
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 claims description 4
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 claims description 4
- 101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 claims description 4
- 208000031671 Large B-Cell Diffuse Lymphoma Diseases 0.000 claims description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 4
- 101150047390 MCP gene Proteins 0.000 claims description 4
- 108010000684 Matrix Metalloproteinases Proteins 0.000 claims description 4
- 102000002274 Matrix Metalloproteinases Human genes 0.000 claims description 4
- 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 claims description 4
- 108091027766 Mir-143 Proteins 0.000 claims description 4
- 101150109748 UL19 gene Proteins 0.000 claims description 4
- 108010017070 Zinc Finger Nucleases Proteins 0.000 claims description 4
- 230000000947 anti-immunosuppressive effect Effects 0.000 claims description 4
- 210000004958 brain cell Anatomy 0.000 claims description 4
- 206010012818 diffuse large B-cell lymphoma Diseases 0.000 claims description 4
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims description 4
- 231100000844 hepatocellular carcinoma Toxicity 0.000 claims description 4
- 210000003494 hepatocyte Anatomy 0.000 claims description 4
- 201000007270 liver cancer Diseases 0.000 claims description 4
- 208000014018 liver neoplasm Diseases 0.000 claims description 4
- 201000005202 lung cancer Diseases 0.000 claims description 4
- 208000020816 lung neoplasm Diseases 0.000 claims description 4
- 201000007924 marginal zone B-cell lymphoma Diseases 0.000 claims description 4
- 208000021937 marginal zone lymphoma Diseases 0.000 claims description 4
- 108091024038 miR-133a stem-loop Proteins 0.000 claims description 4
- 108091071651 miR-208 stem-loop Proteins 0.000 claims description 4
- 108091084446 miR-208a stem-loop Proteins 0.000 claims description 4
- 108091062547 miR-208a-1 stem-loop Proteins 0.000 claims description 4
- 108091055375 miR-208a-2 stem-loop Proteins 0.000 claims description 4
- 230000000174 oncolytic effect Effects 0.000 claims description 4
- 210000000278 spinal cord Anatomy 0.000 claims description 4
- 210000002948 striated muscle cell Anatomy 0.000 claims description 4
- 230000003612 virological effect Effects 0.000 claims description 4
- ZKRFOXLVOKTUTA-KQYNXXCUSA-N 9-(5-phosphoribofuranosyl)-6-mercaptopurine Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=S)=C2N=C1 ZKRFOXLVOKTUTA-KQYNXXCUSA-N 0.000 claims description 3
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims description 3
- 102100031780 Endonuclease Human genes 0.000 claims description 3
- 102000004533 Endonucleases Human genes 0.000 claims description 3
- 101000834898 Homo sapiens Alpha-synuclein Proteins 0.000 claims description 3
- 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 claims description 3
- 101000652359 Homo sapiens Spermatogenesis-associated protein 2 Proteins 0.000 claims description 3
- 108091007773 MIR100 Proteins 0.000 claims description 3
- 108091028232 Mir-184 Proteins 0.000 claims description 3
- 102100040678 Programmed cell death protein 1 Human genes 0.000 claims description 3
- 108091091807 let-7a stem-loop Proteins 0.000 claims description 3
- 108091057746 let-7a-4 stem-loop Proteins 0.000 claims description 3
- 108091028376 let-7a-5 stem-loop Proteins 0.000 claims description 3
- 108091024393 let-7a-6 stem-loop Proteins 0.000 claims description 3
- 108091091174 let-7a-7 stem-loop Proteins 0.000 claims description 3
- 108091044592 miR-1-1 stem-loop Proteins 0.000 claims description 3
- 108091045542 miR-1-2 stem-loop Proteins 0.000 claims description 3
- 108091047831 miR-1-3 stem-loop Proteins 0.000 claims description 3
- 108091031494 miR-1-4 stem-loop Proteins 0.000 claims description 3
- 108091091360 miR-125b stem-loop Proteins 0.000 claims description 3
- 108091047757 miR-133a-1 stem-loop Proteins 0.000 claims description 3
- 108091057540 miR-133a-2 stem-loop Proteins 0.000 claims description 3
- 108091055152 miR-133a-3 stem-loop Proteins 0.000 claims description 3
- 108091079016 miR-133b Proteins 0.000 claims description 3
- 108091043162 miR-133b stem-loop Proteins 0.000 claims description 3
- 108091043597 miR-134 stem-loop Proteins 0.000 claims description 3
- 108091073532 miR-143 stem-loop Proteins 0.000 claims description 3
- 108091053592 miR-145-1 stem-loop Proteins 0.000 claims description 3
- 108091056559 miR-145-2 stem-loop Proteins 0.000 claims description 3
- 108091025686 miR-199a stem-loop Proteins 0.000 claims description 3
- 108091083769 miR-199a-1 stem-loop Proteins 0.000 claims description 3
- 108091047470 miR-199a-2 stem-loop Proteins 0.000 claims description 3
- 108091048350 miR-199a-3 stem-loop Proteins 0.000 claims description 3
- 108091056793 miR-199a-4 stem-loop Proteins 0.000 claims description 3
- 108091037622 miR-233 stem-loop Proteins 0.000 claims description 3
- 108091064010 miR-31 stem-loop Proteins 0.000 claims description 3
- 108091066670 miR-31-1 stem-loop Proteins 0.000 claims description 3
- 108091054015 miR-31-2 stem-loop Proteins 0.000 claims description 3
- 108091028785 miR-31-3 stem-loop Proteins 0.000 claims description 3
- 108091029119 miR-34a stem-loop Proteins 0.000 claims description 3
- 108091032770 miR-451 stem-loop Proteins 0.000 claims description 3
- 108091030646 miR-451a stem-loop Proteins 0.000 claims description 3
- 108091061974 miR-559 stem-loop Proteins 0.000 claims description 3
- 108091076732 miR-99a stem-loop Proteins 0.000 claims description 3
- 108091064318 miR-99a-1 stem-loop Proteins 0.000 claims description 3
- 108091086202 miR-99a-2 stem-loop Proteins 0.000 claims description 3
- 210000001428 peripheral nervous system Anatomy 0.000 claims description 3
- 210000000329 smooth muscle myocyte Anatomy 0.000 claims description 3
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims description 2
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims description 2
- 206010006187 Breast cancer Diseases 0.000 claims description 2
- 208000026310 Breast neoplasm Diseases 0.000 claims description 2
- 102100032367 C-C motif chemokine 5 Human genes 0.000 claims description 2
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 claims description 2
- 102100025277 C-X-C motif chemokine 13 Human genes 0.000 claims description 2
- 108010056102 CD100 antigen Proteins 0.000 claims description 2
- 102100032912 CD44 antigen Human genes 0.000 claims description 2
- 101710172824 CRISPR-associated endonuclease Cas9 Proteins 0.000 claims description 2
- 101150018129 CSF2 gene Proteins 0.000 claims description 2
- 101150069031 CSN2 gene Proteins 0.000 claims description 2
- 108010021064 CTLA-4 Antigen Proteins 0.000 claims description 2
- 229940045513 CTLA4 antagonist Drugs 0.000 claims description 2
- 101100274575 Caenorhabditis elegans clh-3 gene Proteins 0.000 claims description 2
- 102000011727 Caspases Human genes 0.000 claims description 2
- 108010076667 Caspases Proteins 0.000 claims description 2
- 206010008342 Cervix carcinoma Diseases 0.000 claims description 2
- 206010009944 Colon cancer Diseases 0.000 claims description 2
- 108091008794 FGF receptors Proteins 0.000 claims description 2
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 2
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims description 2
- 102100023600 Fibroblast growth factor receptor 2 Human genes 0.000 claims description 2
- 101710182389 Fibroblast growth factor receptor 2 Proteins 0.000 claims description 2
- 206010018338 Glioma Diseases 0.000 claims description 2
- 108090000288 Glycoproteins Proteins 0.000 claims description 2
- 102000003886 Glycoproteins Human genes 0.000 claims description 2
- 229920002971 Heparan sulfate Polymers 0.000 claims description 2
- 102100022623 Hepatocyte growth factor receptor Human genes 0.000 claims description 2
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims description 2
- 101000797762 Homo sapiens C-C motif chemokine 5 Proteins 0.000 claims description 2
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 claims description 2
- 101000858064 Homo sapiens C-X-C motif chemokine 13 Proteins 0.000 claims description 2
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 2
- 101000972946 Homo sapiens Hepatocyte growth factor receptor Proteins 0.000 claims description 2
- 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 claims description 2
- 101001098352 Homo sapiens OX-2 membrane glycoprotein Proteins 0.000 claims description 2
- 101000610551 Homo sapiens Prominin-1 Proteins 0.000 claims description 2
- 101000766306 Homo sapiens Serotransferrin Proteins 0.000 claims description 2
- 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 claims description 2
- 101000622304 Homo sapiens Vascular cell adhesion protein 1 Proteins 0.000 claims description 2
- 102100022339 Integrin alpha-L Human genes 0.000 claims description 2
- 102000003812 Interleukin-15 Human genes 0.000 claims description 2
- 108090000172 Interleukin-15 Proteins 0.000 claims description 2
- 108010002350 Interleukin-2 Proteins 0.000 claims description 2
- 102000000588 Interleukin-2 Human genes 0.000 claims description 2
- 102100030703 Interleukin-22 Human genes 0.000 claims description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
- 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 claims description 2
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 claims description 2
- 102100028198 Macrophage colony-stimulating factor 1 receptor Human genes 0.000 claims description 2
- 101710150918 Macrophage colony-stimulating factor 1 receptor Proteins 0.000 claims description 2
- 102000005741 Metalloproteases Human genes 0.000 claims description 2
- 108010006035 Metalloproteases Proteins 0.000 claims description 2
- 108091028080 MiR-132 Proteins 0.000 claims description 2
- 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 claims description 2
- 101100385413 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) csm-3 gene Proteins 0.000 claims description 2
- 102100037589 OX-2 membrane glycoprotein Human genes 0.000 claims description 2
- 206010033128 Ovarian cancer Diseases 0.000 claims description 2
- 206010061535 Ovarian neoplasm Diseases 0.000 claims description 2
- 108091081548 Palindromic sequence Proteins 0.000 claims description 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 2
- 102100040120 Prominin-1 Human genes 0.000 claims description 2
- 206010060862 Prostate cancer Diseases 0.000 claims description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 2
- 208000015634 Rectal Neoplasms Diseases 0.000 claims description 2
- 102100027744 Semaphorin-4D Human genes 0.000 claims description 2
- 102000012479 Serine Proteases Human genes 0.000 claims description 2
- 108010022999 Serine Proteases Proteins 0.000 claims description 2
- 108010007945 Smad Proteins Proteins 0.000 claims description 2
- 102000007374 Smad Proteins Human genes 0.000 claims description 2
- 206010041067 Small cell lung cancer Diseases 0.000 claims description 2
- 108091027967 Small hairpin RNA Proteins 0.000 claims description 2
- 101710196623 Stimulator of interferon genes protein Proteins 0.000 claims description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 claims description 2
- 101000910035 Streptococcus pyogenes serotype M1 CRISPR-associated endonuclease Cas9/Csn1 Proteins 0.000 claims description 2
- 208000024313 Testicular Neoplasms Diseases 0.000 claims description 2
- 206010057644 Testis cancer Diseases 0.000 claims description 2
- 102100026144 Transferrin receptor protein 1 Human genes 0.000 claims description 2
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 2
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 2
- 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 claims description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims description 2
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 claims description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 2
- 230000004913 activation Effects 0.000 claims description 2
- 229940009098 aspartate Drugs 0.000 claims description 2
- 201000000053 blastoma Diseases 0.000 claims description 2
- 230000030833 cell death Effects 0.000 claims description 2
- 201000010881 cervical cancer Diseases 0.000 claims description 2
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 claims description 2
- 230000000112 colonic effect Effects 0.000 claims description 2
- 208000029742 colonic neoplasm Diseases 0.000 claims description 2
- 101150055601 cops2 gene Proteins 0.000 claims description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 2
- 235000018417 cysteine Nutrition 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 239000012636 effector Substances 0.000 claims description 2
- 201000008184 embryoma Diseases 0.000 claims description 2
- 108010087914 epidermal growth factor receptor VIII Proteins 0.000 claims description 2
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims description 2
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims description 2
- 102000052178 fibroblast growth factor receptor activity proteins Human genes 0.000 claims description 2
- 206010017758 gastric cancer Diseases 0.000 claims description 2
- 239000003292 glue Substances 0.000 claims description 2
- 208000029824 high grade glioma Diseases 0.000 claims description 2
- 230000002163 immunogen Effects 0.000 claims description 2
- 238000001727 in vivo Methods 0.000 claims description 2
- 108010074108 interleukin-21 Proteins 0.000 claims description 2
- 210000004185 liver Anatomy 0.000 claims description 2
- 201000011614 malignant glioma Diseases 0.000 claims description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 2
- 201000001441 melanoma Diseases 0.000 claims description 2
- 239000003475 metalloproteinase inhibitor Substances 0.000 claims description 2
- 108091043249 miR-135-1 stem-loop Proteins 0.000 claims description 2
- 108091064876 miR-135-2 stem-loop Proteins 0.000 claims description 2
- 108091092012 miR-199b stem-loop Proteins 0.000 claims description 2
- 108091063796 miR-206 stem-loop Proteins 0.000 claims description 2
- 108091035328 miR-217 stem-loop Proteins 0.000 claims description 2
- 108091039135 miR-217-1 stem-loop Proteins 0.000 claims description 2
- 108091029206 miR-217-2 stem-loop Proteins 0.000 claims description 2
- 108091063344 miR-30b stem-loop Proteins 0.000 claims description 2
- 108091023108 miR-30e stem-loop Proteins 0.000 claims description 2
- 108091027983 miR-378-1 stem-loop Proteins 0.000 claims description 2
- 108091089716 miR-378-2 stem-loop Proteins 0.000 claims description 2
- 108091070757 miR-378i stem-loop Proteins 0.000 claims description 2
- 108091054004 miR-4284 stem-loop Proteins 0.000 claims description 2
- 108091062429 miR-487b stem-loop Proteins 0.000 claims description 2
- 108091048941 miR-499a stem-loop Proteins 0.000 claims description 2
- 108091055140 miR-574 stem-loop Proteins 0.000 claims description 2
- 108091058485 miR-574-1 stem-loop Proteins 0.000 claims description 2
- 108091055064 miR-574-2 stem-loop Proteins 0.000 claims description 2
- 108091048173 miR-577 stem-loop Proteins 0.000 claims description 2
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims description 2
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 201000002528 pancreatic cancer Diseases 0.000 claims description 2
- 208000008443 pancreatic carcinoma Diseases 0.000 claims description 2
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 claims description 2
- 108020003175 receptors Proteins 0.000 claims description 2
- 102000005962 receptors Human genes 0.000 claims description 2
- 206010038038 rectal cancer Diseases 0.000 claims description 2
- 201000001275 rectum cancer Diseases 0.000 claims description 2
- 239000004055 small Interfering RNA Substances 0.000 claims description 2
- 208000000587 small cell lung carcinoma Diseases 0.000 claims description 2
- 201000011549 stomach cancer Diseases 0.000 claims description 2
- 230000008685 targeting Effects 0.000 claims description 2
- 201000003120 testicular cancer Diseases 0.000 claims description 2
- 208000013077 thyroid gland carcinoma Diseases 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 claims description 2
- 230000002103 transcriptional effect Effects 0.000 claims description 2
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 2
- 230000003213 activating effect Effects 0.000 claims 2
- 102100020715 Fms-related tyrosine kinase 3 ligand protein Human genes 0.000 claims 1
- 101710162577 Fms-related tyrosine kinase 3 ligand protein Proteins 0.000 claims 1
- 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 230000006798 recombination Effects 0.000 claims 1
- 238000005215 recombination Methods 0.000 claims 1
- 241001529453 unidentified herpesvirus Species 0.000 claims 1
- 238000000034 method Methods 0.000 description 15
- 230000000711 cancerogenic effect Effects 0.000 description 4
- 101150090364 ICP0 gene Proteins 0.000 description 3
- 231100000315 carcinogenic Toxicity 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 101001047640 Homo sapiens Linker for activation of T-cells family member 1 Proteins 0.000 description 2
- 101000702132 Homo sapiens Protein spinster homolog 1 Proteins 0.000 description 2
- 102100026799 Matrix metalloproteinase-28 Human genes 0.000 description 2
- 101150041636 NEC1 gene Proteins 0.000 description 2
- 101001038499 Yarrowia lipolytica (strain CLIB 122 / E 150) Lysine acetyltransferase Proteins 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000007634 remodeling Methods 0.000 description 2
- VKUYLANQOAKALN-UHFFFAOYSA-N 2-[benzyl-(4-methoxyphenyl)sulfonylamino]-n-hydroxy-4-methylpentanamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N(C(CC(C)C)C(=O)NO)CC1=CC=CC=C1 VKUYLANQOAKALN-UHFFFAOYSA-N 0.000 description 1
- 102100026802 72 kDa type IV collagenase Human genes 0.000 description 1
- 101710151806 72 kDa type IV collagenase Proteins 0.000 description 1
- 101150072608 CVC1 gene Proteins 0.000 description 1
- 101150010802 CVC2 gene Proteins 0.000 description 1
- 102100027995 Collagenase 3 Human genes 0.000 description 1
- 108050005238 Collagenase 3 Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 101150109586 Gk gene Proteins 0.000 description 1
- 101001011896 Homo sapiens Matrix metalloproteinase-19 Proteins 0.000 description 1
- 101000627854 Homo sapiens Matrix metalloproteinase-26 Proteins 0.000 description 1
- 101000627861 Homo sapiens Matrix metalloproteinase-28 Proteins 0.000 description 1
- 101000645296 Homo sapiens Metalloproteinase inhibitor 2 Proteins 0.000 description 1
- 101000831266 Homo sapiens Metalloproteinase inhibitor 4 Proteins 0.000 description 1
- 101100048372 Human cytomegalovirus (strain AD169) H301 gene Proteins 0.000 description 1
- 101100048373 Human cytomegalovirus (strain Merlin) UL18 gene Proteins 0.000 description 1
- 102100027998 Macrophage metalloelastase Human genes 0.000 description 1
- 101710187853 Macrophage metalloelastase Proteins 0.000 description 1
- 102100030417 Matrilysin Human genes 0.000 description 1
- 108090000855 Matrilysin Proteins 0.000 description 1
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 1
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 1
- 108010076557 Matrix Metalloproteinase 14 Proteins 0.000 description 1
- 102100030216 Matrix metalloproteinase-14 Human genes 0.000 description 1
- 102100030201 Matrix metalloproteinase-15 Human genes 0.000 description 1
- 108090000560 Matrix metalloproteinase-15 Proteins 0.000 description 1
- 102100030200 Matrix metalloproteinase-16 Human genes 0.000 description 1
- 108090000561 Matrix metalloproteinase-16 Proteins 0.000 description 1
- 102100030219 Matrix metalloproteinase-17 Human genes 0.000 description 1
- 108090000585 Matrix metalloproteinase-17 Proteins 0.000 description 1
- 102100030218 Matrix metalloproteinase-19 Human genes 0.000 description 1
- 108090000587 Matrix metalloproteinase-19 Proteins 0.000 description 1
- 102000004055 Matrix metalloproteinase-19 Human genes 0.000 description 1
- 101710082411 Matrix metalloproteinase-21 Proteins 0.000 description 1
- 102100024130 Matrix metalloproteinase-23 Human genes 0.000 description 1
- 102100024129 Matrix metalloproteinase-24 Human genes 0.000 description 1
- 108050005214 Matrix metalloproteinase-24 Proteins 0.000 description 1
- 102100024128 Matrix metalloproteinase-26 Human genes 0.000 description 1
- 102100024132 Matrix metalloproteinase-27 Human genes 0.000 description 1
- 108050005201 Matrix metalloproteinase-27 Proteins 0.000 description 1
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 1
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 1
- 102100026262 Metalloproteinase inhibitor 2 Human genes 0.000 description 1
- 102100026261 Metalloproteinase inhibitor 3 Human genes 0.000 description 1
- 102100024289 Metalloproteinase inhibitor 4 Human genes 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 101150098384 NEC2 gene Proteins 0.000 description 1
- 102100030411 Neutrophil collagenase Human genes 0.000 description 1
- 101710118230 Neutrophil collagenase Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 101150030723 RIR2 gene Proteins 0.000 description 1
- 101150103019 SCP gene Proteins 0.000 description 1
- 102100030416 Stromelysin-1 Human genes 0.000 description 1
- 101710108790 Stromelysin-1 Proteins 0.000 description 1
- 102100028848 Stromelysin-2 Human genes 0.000 description 1
- 101710108792 Stromelysin-2 Proteins 0.000 description 1
- 102100028847 Stromelysin-3 Human genes 0.000 description 1
- 108050005271 Stromelysin-3 Proteins 0.000 description 1
- 101150110861 TRM2 gene Proteins 0.000 description 1
- 101150048584 TRM3 gene Proteins 0.000 description 1
- 101150102071 TRX1 gene Proteins 0.000 description 1
- 101150037769 TRX2 gene Proteins 0.000 description 1
- 108010031429 Tissue Inhibitor of Metalloproteinase-3 Proteins 0.000 description 1
- 101150111135 UL1 gene Proteins 0.000 description 1
- 101150087840 UL11 gene Proteins 0.000 description 1
- 101150023763 UL12 gene Proteins 0.000 description 1
- 101150036407 UL14 gene Proteins 0.000 description 1
- 101150104047 UL17 gene Proteins 0.000 description 1
- 101150050388 UL20 gene Proteins 0.000 description 1
- 101150004957 UL25 gene Proteins 0.000 description 1
- 101150060044 UL26 gene Proteins 0.000 description 1
- 101150003230 UL27 gene Proteins 0.000 description 1
- 101150072074 UL28 gene Proteins 0.000 description 1
- 101150008036 UL29 gene Proteins 0.000 description 1
- 101150019585 UL31 gene Proteins 0.000 description 1
- 101150081727 UL32 gene Proteins 0.000 description 1
- 101150017804 UL33 gene Proteins 0.000 description 1
- 101150087430 UL34 gene Proteins 0.000 description 1
- 101150023000 UL35 gene Proteins 0.000 description 1
- 101150036065 UL37 gene Proteins 0.000 description 1
- 101150090946 UL38 gene Proteins 0.000 description 1
- 101150100826 UL40 gene Proteins 0.000 description 1
- 101150004685 UL48 gene Proteins 0.000 description 1
- 101150066971 UL49 gene Proteins 0.000 description 1
- 101150011902 UL52 gene Proteins 0.000 description 1
- 101150009795 UL54 gene Proteins 0.000 description 1
- 101150033660 UL6 gene Proteins 0.000 description 1
- 101150095805 UL7 gene Proteins 0.000 description 1
- 102100031358 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 101001011890 Xenopus laevis Matrix metalloproteinase-18 Proteins 0.000 description 1
- 230000005975 antitumor immune response Effects 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 101150029683 gB gene Proteins 0.000 description 1
- 101150055782 gH gene Proteins 0.000 description 1
- 101150015940 gL gene Proteins 0.000 description 1
- 108090000440 matrix metalloproteinase 25 Proteins 0.000 description 1
- 108091079012 miR-133a Proteins 0.000 description 1
- 101150046896 trm1 gene Proteins 0.000 description 1
- 102000009816 urokinase plasminogen activator receptor activity proteins Human genes 0.000 description 1
- 108040001269 urokinase plasminogen activator receptor activity proteins Proteins 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023043321A JP7652823B2 (ja) | 2017-07-26 | 2023-03-17 | 腫瘍溶解性ウイルスベクター及びその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762537359P | 2017-07-26 | 2017-07-26 | |
| US62/537,359 | 2017-07-26 | ||
| US201862686802P | 2018-06-19 | 2018-06-19 | |
| US62/686,802 | 2018-06-19 | ||
| PCT/US2018/043938 WO2019023483A1 (en) | 2017-07-26 | 2018-07-26 | ONCOLYTIC VIRAL VECTORS AND USES THEREOF |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023043321A Division JP7652823B2 (ja) | 2017-07-26 | 2023-03-17 | 腫瘍溶解性ウイルスベクター及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020532951A JP2020532951A (ja) | 2020-11-19 |
| JP2020532951A5 true JP2020532951A5 (enExample) | 2021-08-26 |
| JP7249323B2 JP7249323B2 (ja) | 2023-03-30 |
Family
ID=65040409
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020504236A Active JP7249323B2 (ja) | 2017-07-26 | 2018-07-26 | 腫瘍溶解性ウイルスベクター及びその使用 |
| JP2023043321A Active JP7652823B2 (ja) | 2017-07-26 | 2023-03-17 | 腫瘍溶解性ウイルスベクター及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023043321A Active JP7652823B2 (ja) | 2017-07-26 | 2023-03-17 | 腫瘍溶解性ウイルスベクター及びその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11612625B2 (enExample) |
| EP (1) | EP3658165A4 (enExample) |
| JP (2) | JP7249323B2 (enExample) |
| KR (1) | KR20200042904A (enExample) |
| CN (1) | CN111212656B (enExample) |
| AU (1) | AU2018306455A1 (enExample) |
| BR (1) | BR112020001559A2 (enExample) |
| CA (1) | CA3070299A1 (enExample) |
| IL (1) | IL271993A (enExample) |
| MX (1) | MX2020000993A (enExample) |
| RU (1) | RU2771110C2 (enExample) |
| SG (1) | SG11202000691XA (enExample) |
| WO (1) | WO2019023483A1 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201806134SA (en) * | 2016-01-27 | 2018-08-30 | Oncorus Inc | Oncolytic viral vectors and uses thereof |
| US11612625B2 (en) | 2017-07-26 | 2023-03-28 | Oncorus, Inc. | Oncolytic viral vectors and uses thereof |
| CA3085662A1 (en) * | 2017-12-14 | 2019-06-20 | Unicyte Ev Ag | Pharmaceutical carriers containing mirnas for use in the treatment of renal cancer |
| KR20210098483A (ko) * | 2018-11-29 | 2021-08-10 | 바이로진 바이오테크 캐나다 리미티드 | 신경독성이 감소된 hsv 벡터 |
| CN113439123A (zh) * | 2019-03-05 | 2021-09-24 | 安进公司 | 溶瘤病毒用于治疗癌症的用途 |
| CN110283794B (zh) * | 2019-05-30 | 2021-04-23 | 伍泽堂 | 重组溶瘤病毒以及制备方法、应用和药物 |
| AU2020326774A1 (en) * | 2019-08-05 | 2022-03-03 | Virogin Biotech Canada Ltd | Genetically modified enterovirus vectors |
| CN111235274A (zh) * | 2020-01-18 | 2020-06-05 | 山西医科大学第一医院 | 喉鳞癌血清外泌体标志物筛选方法和外泌体来源miR-941应用 |
| ES2856232B2 (es) * | 2020-03-25 | 2023-11-24 | Fundacion Para La Investig Biomedica Del Hospital 12 De Octubre | Biomarcadores para predecir la respuesta de un sujeto a una terapia con bcg, metodos y usos basados en los mismos |
| US20240226208A9 (en) * | 2020-04-15 | 2024-07-11 | Humane Genomics Inc. | Artificial oncolytic viruses and related methods |
| TWI845834B (zh) * | 2020-04-23 | 2024-06-21 | 輔仁大學學校財團法人輔仁大學 | 癌症化療藥物促敏方法、其促敏劑組合物及其用途 |
| CN113583977B (zh) * | 2020-04-30 | 2025-06-06 | 杭州康万达医药科技有限公司 | 可受微小rna调控的分离的重组溶瘤痘病毒及其应用 |
| CN111494636A (zh) * | 2020-06-22 | 2020-08-07 | 中国人民解放军空军军医大学 | Mct1抑制剂的应用及含有其的药物组合物 |
| JP2023540427A (ja) * | 2020-07-07 | 2023-09-25 | オリエンジーン バイオテクノロジー リミテッド | Ｈｓｖ－１遺伝子編集のためのガイドｒｎａおよびその方法 |
| US20230242994A1 (en) * | 2020-07-10 | 2023-08-03 | Shanghai Miran Biotech Co., Ltd. | Fluorescent cross-linked rnase h mutant conjugate, mirna combination and application thereof |
| US11505607B2 (en) * | 2020-11-13 | 2022-11-22 | Binhui Biopharmaceutical Co., Ltd. | Bispecific single-chain antibody, recombinant oncolytic virus for expressing same and virus composition |
| CN116744951A (zh) * | 2020-12-25 | 2023-09-12 | 苏州系统医学研究所 | 一种包含溶瘤病毒的组合物及其在肿瘤治疗中的应用 |
| WO2022151078A1 (zh) * | 2021-01-13 | 2022-07-21 | 嘉兴允英医学检验有限公司 | 溶瘤病毒及其应用 |
| JP2024509084A (ja) * | 2021-02-23 | 2024-02-29 | インターギャラクティック セラピューティクス インコーポレイテッド | 核酸ベクター及び使用方法 |
| JP2024512053A (ja) * | 2021-03-24 | 2024-03-18 | ヴァイロジン バイオテック カナダ リミテッド | 転写及び翻訳の二重調節を受ける腫瘍溶解性単純ヘルペスウイルスベクター |
| JP2024532622A (ja) * | 2021-08-31 | 2024-09-05 | ヴィロジェン バイオテック カナダ リミテッド | 操作された腫瘍溶解性ヘルペスウイルス |
| EP4170022A1 (en) * | 2021-10-19 | 2023-04-26 | Consejo Superior De Investigaciones Científicas | Recombinant african swine fever virus and uses thereof |
| CN114010666B (zh) * | 2021-10-22 | 2024-05-07 | 上海交通大学 | 溶瘤病毒、parp抑制剂及pd-1抗体在制备抗肿瘤药物中的应用 |
| EP4482505A2 (en) * | 2022-02-22 | 2025-01-01 | Vyro Bio Inc. | Oncolytic viruses and methods of use |
| CN117379389A (zh) * | 2022-07-12 | 2024-01-12 | 四川大学 | 血小板-溶瘤病毒复合物、其制备方法及其应用 |
| WO2024054293A1 (en) * | 2022-09-08 | 2024-03-14 | Research Institute At Nationwide Children's Hospital | Oncolytic virus combination to maximize oncolytic activity |
| WO2024134495A1 (en) * | 2022-12-20 | 2024-06-27 | Janssen Biotech, Inc. | Oncolytic virus and uses thereof |
| GB2634272A (en) * | 2023-10-04 | 2025-04-09 | Averywell Ltd | Methods |
Family Cites Families (112)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5244792A (en) | 1984-04-06 | 1993-09-14 | Chiron Corporation | Expression of recombinant glyoprotein B from herpes simplex virus |
| JPH0668B2 (ja) | 1985-08-30 | 1994-01-05 | 財団法人化学及血清療法研究所 | 単純ヘルペスウイルス遺伝子が組込まれた組換えプラスミド |
| GB8918616D0 (en) | 1989-08-15 | 1989-09-27 | Univ Glasgow | Herpes simplex virus type 1 mutant |
| US5725871A (en) | 1989-08-18 | 1998-03-10 | Danbiosyst Uk Limited | Drug delivery compositions comprising lysophosphoglycerolipid |
| US5707644A (en) | 1989-11-04 | 1998-01-13 | Danbiosyst Uk Limited | Small particle compositions for intranasal drug delivery |
| US5466468A (en) | 1990-04-03 | 1995-11-14 | Ciba-Geigy Corporation | Parenterally administrable liposome formulation comprising synthetic lipids |
| US5849572A (en) | 1990-10-10 | 1998-12-15 | Regents Of The University Of Michigan | HSV-1 vector containing a lat promoter |
| US5849571A (en) | 1990-10-10 | 1998-12-15 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Latency active herpes virus promoters and their use |
| US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| US5756353A (en) | 1991-12-17 | 1998-05-26 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol-and liposome-based delivery |
| WO1993023011A1 (en) | 1992-05-18 | 1993-11-25 | Minnesota Mining And Manufacturing Company | Transmucosal drug delivery device |
| US5879934A (en) | 1992-07-31 | 1999-03-09 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Herpes simplex virus strains for gene transfer |
| US5804413A (en) | 1992-07-31 | 1998-09-08 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Herpes simplex virus strains for gene transfer |
| US5658724A (en) | 1992-07-31 | 1997-08-19 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Herpes simplex virus strains deficient for the essential immediate early genes ICP4 and ICP27 and methods for their production, growth and use |
| US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
| GB9415369D0 (en) | 1994-07-29 | 1994-09-21 | Lynxvale Ltd | Mutant virus |
| GB9415319D0 (en) | 1994-07-29 | 1994-09-21 | Medical Res Council | HSV viral vector |
| IE80468B1 (en) | 1995-04-04 | 1998-07-29 | Elan Corp Plc | Controlled release biodegradable nanoparticles containing insulin |
| US6261552B1 (en) | 1997-05-22 | 2001-07-17 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Herpes simplex virus vectors |
| GB9700411D0 (en) | 1997-01-10 | 1997-02-26 | Univ London | Eukaryotic gene expression cassette and uses thereof |
| US6071742A (en) | 1997-03-05 | 2000-06-06 | Board Of Regents Of The University Of Nebraska | Coxsackie virus as a vector for delivery of anti-inflammatory cytokines |
| US5998174A (en) | 1997-05-12 | 1999-12-07 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Multigene vectors |
| AU8605598A (en) | 1997-07-31 | 1999-02-22 | University Of Pittsburgh | Targeted hsv vectors |
| EP1037991B1 (en) | 1997-12-17 | 2005-09-28 | Immunex Corporation | Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides |
| GB9810423D0 (en) | 1998-05-15 | 1998-07-15 | Cancer Res Campaign Tech | Ionizing radiation or diathermy-switched gene therapy vectors and their use in antitumour therapy |
| EP1002864A1 (en) | 1998-11-10 | 2000-05-24 | Universita' degli studi di Bologna | HIgR and related V domain for the manufacture of a medicament for preventing or treating HSV-1, HSV-2 and BHV infections |
| US6897057B1 (en) | 1999-08-31 | 2005-05-24 | The General Hospital Corporation | Cell-specific and/or tumor-specific promoter retargeting of herpes γ 34.5 gene expression |
| GB9930418D0 (en) | 1999-12-22 | 2000-02-16 | Neurovex Ltd | Replication incompetent herpes virus vectors |
| ES2366608T3 (es) | 2001-03-27 | 2011-10-21 | The General Hospital Corporation | Vectores víricos y su uso en métodos terapéuticos. |
| US20020187126A1 (en) | 2001-04-06 | 2002-12-12 | Mount Sinai School Of Medicine | Methods for viral oncoapoptosis in cancer therapy |
| EP1451333B1 (en) | 2001-10-04 | 2009-06-24 | Immunex Corporation | Ul16 binding protein 4 |
| KR100900249B1 (ko) | 2001-12-07 | 2009-05-29 | 포항공과대학교 산학협력단 | ＳＩＶｍａｃ239의 면역원성 플라스미드 및 이들을 함유한ＡＩＤＳ ＤＮＡ 백신 |
| AU2003216502B2 (en) | 2002-03-01 | 2008-04-10 | Sloan-Kettering Institute For Cancer Research | Prevention of recurrence and metastasis of cancer |
| US8927251B2 (en) | 2002-10-07 | 2015-01-06 | The University Of Chicago | Targeting of herpes simplex virus to specific receptors |
| EP1717317A4 (en) | 2004-01-22 | 2009-02-11 | Dnavec Research Inc | METHOD OF GENERATING VIRAL NEGATIVE STRAND RNA VECTORS USING A HYBRID PROMOTER COMPRISING THE CYTOMEGALOVIRUS ENHANCER AND THE BETA ACTIN PROMOTER FROM CHICKEN |
| GB0406389D0 (en) | 2004-03-22 | 2004-04-21 | Istituto Superiore Di Sanito | Recombinant herpes simplex virus and uses therefor |
| US7473418B2 (en) | 2004-03-25 | 2009-01-06 | Cell Genesys, Inc. | Pan cancer oncolytic vectors and methods of use thereof |
| US8236298B2 (en) | 2004-08-20 | 2012-08-07 | Viralytics Limited | Methods and compositions for treatment of hematologic cancers |
| CN101203530A (zh) | 2004-10-28 | 2008-06-18 | 匹兹堡大学高等教育联邦体系 | 关于脊髓损伤疼痛的外周递送的谷氨酸脱羧酶基因治疗 |
| CN101132798B (zh) | 2005-01-17 | 2011-04-27 | 溶瘤病毒有限公司 | 核酸分子在制备用于治疗黑色素瘤的药物中的应用及其组合物 |
| HUE027013T2 (en) * | 2005-05-27 | 2016-10-28 | Ospedale San Raffaele Srl | A gene vector containing MI-RNA |
| EP3284833B1 (en) | 2005-08-26 | 2021-12-01 | DuPont Nutrition Biosciences ApS | Use of crispr associated genes (cas) |
| US8980246B2 (en) | 2005-09-07 | 2015-03-17 | Sillajen Biotherapeutics, Inc. | Oncolytic vaccinia virus cancer therapy |
| US20080008686A1 (en) | 2006-07-10 | 2008-01-10 | The Brigham And Women's Hospital, Inc. | Tetracycline repressor regulated oncolytic viruses |
| EP2395081A1 (en) | 2006-08-11 | 2011-12-14 | Dow AgroSciences LLC | Zinc finger nuclease-mediated homologous recombination |
| WO2008103755A1 (en) | 2007-02-20 | 2008-08-28 | Mayo Foundation For Medical Education And Research | Treating cancer with viral nucleic acid |
| US8586028B2 (en) | 2007-05-09 | 2013-11-19 | Board Of Supervisors Of Lousiana State University And Agricultural And Mechanical College | Synthetic herpes simplex viruses type-1 for treatment of cancers |
| WO2008143875A1 (en) | 2007-05-14 | 2008-11-27 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Targeted delivery of glycine receptors to excitable cells |
| WO2009111892A1 (en) | 2008-03-14 | 2009-09-17 | Ottawa Health Research Institute | Microrna mediated oncolytic targeting |
| GB0807424D0 (en) | 2008-04-23 | 2008-05-28 | Isis Innovation | Virus |
| EP2307033A4 (en) | 2008-05-29 | 2012-06-13 | Gen Hospital Corp | USE OF ONCOLYTIC HERPESVIRUS FOR THE KILLING OF CANCER STEM CELLS |
| PL2293804T3 (pl) | 2008-05-29 | 2014-03-31 | Univ Bologna Alma Mater Studiorum | Wirus opryszczki pospolitej (HSV) o zmodyfikowanym tropizmie, jego zastosowanie i sposób przygotowania |
| GB0810912D0 (en) | 2008-06-13 | 2008-07-23 | Inst Animal Health Ltd | Vector |
| US8546553B2 (en) | 2008-07-25 | 2013-10-01 | University Of Georgia Research Foundation, Inc. | Prokaryotic RNAi-like system and methods of use |
| US20100076057A1 (en) | 2008-09-23 | 2010-03-25 | Northwestern University | TARGET DNA INTERFERENCE WITH crRNA |
| US9404098B2 (en) | 2008-11-06 | 2016-08-02 | University Of Georgia Research Foundation, Inc. | Method for cleaving a target RNA using a Cas6 polypeptide |
| MX337838B (es) | 2008-11-07 | 2016-03-22 | Dupont Nutrition Biosci Aps | Secuencias de repetidos palindromicos cortos regularmente intercalados agrupados de bifidobacterias. |
| KR20110128345A (ko) | 2009-03-13 | 2011-11-29 | 에젠, 인코포레이티드 | 생물학적 활성 ｒｎａ의 전달을 위한 조성물 및 방법 |
| US20100297072A1 (en) | 2009-05-19 | 2010-11-25 | Depinho Ronald A | Combinations of Immunostimulatory Agents, Oncolytic Virus, and Additional Anticancer Therapy |
| US20130202639A1 (en) | 2010-03-25 | 2013-08-08 | Konstantin G. Kousoulas | Synthetic Herpes Simplex Viruses for Treatment of Cancers |
| JP5652830B2 (ja) | 2010-04-09 | 2015-01-14 | 国立大学法人 東京大学 | マイクロｒｎａ制御組換えワクシニアウイルス及びその使用 |
| US9593347B2 (en) | 2010-04-16 | 2017-03-14 | University of Pittsburgh—of the Commonwealth System of Higher Education | Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-HSV receptors |
| WO2012006181A2 (en) | 2010-06-29 | 2012-01-12 | Mount Sinai School Of Medicine | Compositions and methods for inhibiting oncogenic micrornas and treatment of cancer |
| NZ607870A (en) | 2010-10-20 | 2015-09-25 | Dupont Nutrition Biosci Aps | Lactococcus crispr-cas sequences |
| PT2702160T (pt) | 2011-04-27 | 2020-07-30 | Amyris Inc | Métodos para modificação genómica |
| US20140113376A1 (en) | 2011-06-01 | 2014-04-24 | Rotem Sorek | Compositions and methods for downregulating prokaryotic genes |
| EP2543734A1 (en) | 2011-07-07 | 2013-01-09 | Deutsches Krebsforschungszentrum | Adeno-parvovirus chimera with enhanced oncolytical potential |
| EP2591796A1 (en) | 2011-11-10 | 2013-05-15 | Universität Zürich | Combination medicament comprising IL-12 and an anti-CTLA-4 ligand for tumor therapy |
| US11951157B2 (en) | 2011-10-11 | 2024-04-09 | Universitat Zurich | Methods of treating malignant tumour with IL-12 and anti-PD-1 antibody |
| ES2888249T3 (es) | 2011-10-11 | 2022-01-03 | Univ Zuerich | Medicamento de combinación que comprende IL-12 y un agente para el bloqueo de moléculas inhibidoras de linfocitos T para terapia tumoral |
| US20130156808A1 (en) | 2011-11-22 | 2013-06-20 | Stipan Jonjic | Vaccine comprising beta-herpesvirus |
| GB201122458D0 (en) | 2011-12-30 | 2012-02-08 | Univ Wageningen | Modified cascade ribonucleoproteins and uses thereof |
| WO2013109604A1 (en) | 2012-01-19 | 2013-07-25 | Alnylam Pharmaceuticals, Inc. | Viral attenuation and vaccine production |
| SG11201405103SA (en) | 2012-02-24 | 2014-09-26 | Hutchinson Fred Cancer Res | Compositions and methods for the treatment of hemoglobinopathies |
| WO2013141680A1 (en) | 2012-03-20 | 2013-09-26 | Vilnius University | RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX |
| US9637739B2 (en) | 2012-03-20 | 2017-05-02 | Vilnius University | RNA-directed DNA cleavage by the Cas9-crRNA complex |
| HK1210831A1 (en) * | 2013-01-04 | 2016-05-06 | Cytomx Therapeutics Inc. | Compositions and methods for detecting protease activity in biological systems |
| KR20160056869A (ko) * | 2013-06-17 | 2016-05-20 | 더 브로드 인스티튜트, 인코퍼레이티드 | 바이러스 구성성분을 사용하여 장애 및 질환을 표적화하기 위한 crispr-cas 시스템 및 조성물의 전달, 용도 및 치료 적용 |
| EP3022307A4 (en) | 2013-07-17 | 2017-04-19 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Non-toxic hsv vectors for efficient gene delivery applications and complementing cells for their production |
| EP3184641B1 (en) * | 2013-10-28 | 2020-07-08 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Oncolytic hsv vector |
| SG11201607130RA (en) | 2014-02-27 | 2016-09-29 | Viralytics Ltd | Combination method for treatment of cancer |
| CN107073090A (zh) * | 2014-04-30 | 2017-08-18 | 哈佛学院董事会 | 结合的疫苗装置和杀死癌细胞的方法 |
| CN120555373A (zh) | 2014-07-16 | 2025-08-29 | 特兰斯吉恩股份有限公司 | 用于表达免疫检查点调节因子的溶瘤病毒 |
| EP4226936A3 (en) | 2015-03-05 | 2023-09-27 | Northwestern University | Non-neuroinvasive viruses and uses thereof |
| US10083137B2 (en) | 2015-04-02 | 2018-09-25 | Atmel Corporation | Peripheral interface circuit for serial memory |
| US9884704B2 (en) | 2015-08-04 | 2018-02-06 | Ernesto A. Aguero-Hernandez | Clip-clamp with top lock device and method |
| US10210575B1 (en) | 2015-08-12 | 2019-02-19 | State Farm Mutual Automobile Insurance Company | System and method of using an image object as a visual data container |
| IL316210A (en) * | 2015-10-01 | 2024-12-01 | Heat Biologics Inc | Compounds and methods for connecting type 1 and 2 extracellular complexes as heterologous chimeric proteins |
| ES2994611T3 (en) | 2015-10-19 | 2025-01-27 | Cg Oncology Inc | Methods of treating solid or lymphatic tumors by combination therapy |
| CA3045771A1 (en) | 2015-12-02 | 2017-06-08 | Memorial Sloan-Kettering Cancer Center | Seneca valley virus (svv) cellular receptor targeted oncotherapy |
| MY193281A (en) * | 2015-12-17 | 2022-09-30 | Psioxus Therapeutics Ltd | Group b adenovirus encoding an anti-tcr-complex antibody or fragment |
| CN109312309B (zh) | 2016-01-08 | 2024-04-02 | 雷普利穆内有限公司 | 工程化的病毒 |
| SG11201806134SA (en) | 2016-01-27 | 2018-08-30 | Oncorus Inc | Oncolytic viral vectors and uses thereof |
| CN108778301A (zh) | 2016-03-10 | 2018-11-09 | 永恒生物科技股份有限公司 | 通过联合疗法来治疗实体瘤或淋巴瘤的方法 |
| KR102323872B1 (ko) | 2016-04-22 | 2021-11-08 | 임비라 컴퍼니 리미티드 | 암치료용 종양 용해성 단순 헤르페스 바이러스(oHSV) 절대 벡터 및 그 구조체의 구조 |
| AU2017285213B2 (en) | 2016-06-14 | 2024-05-16 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Expression of NKG2D activating ligand proteins for sensitizing cancer cells to attack by cytotoxic immune cells |
| CA3029426A1 (en) * | 2016-06-30 | 2018-01-04 | Oncorus, Inc. | Pseudotyped oncolytic viral delivery of therapeutic polypeptides |
| US12162919B2 (en) | 2016-08-01 | 2024-12-10 | Virogin Biotech Canada Ltd | Oncolytic herpes simplex virus vectors expressing immune system-stimulatory molecules |
| CA3033613A1 (en) | 2016-08-09 | 2018-02-15 | Almohanad ALKAYYAL | Oncolytic rhabdovirus expressing il12 |
| KR102427563B1 (ko) * | 2016-08-29 | 2022-08-03 | 싸이오서스 테라퓨틱스 엘티디. | 이중특이성 T 세포 활성화제(Bispecific T cell activator)가 보강된 아데노바이러스 |
| TW201825674A (zh) | 2016-09-09 | 2018-07-16 | 美商艾斯合顧問有限公司 | 表現雙特異性接合分子的溶瘤病毒 |
| EP3534923A4 (en) | 2016-11-01 | 2020-05-27 | DNAtrix, Inc. | COMBINATION THERAPY FOR THE TREATMENT OF BRAIN CARCINOMAS |
| CN110650745A (zh) | 2016-12-21 | 2020-01-03 | 曼珍有限责任公司 | 武装复制型溶瘤腺病毒 |
| US11298420B2 (en) | 2016-12-21 | 2022-04-12 | Memgen, Llc | Armed oncolytic viruses |
| GB201700350D0 (en) | 2017-01-09 | 2017-02-22 | Replimune Ltd | Altered virus |
| EP3652325A4 (en) | 2017-07-14 | 2021-09-15 | Oncorus, Inc. | ENCAPSULATED POLYNUCLEOTIDES AND METHODS OF USE |
| US11612625B2 (en) | 2017-07-26 | 2023-03-28 | Oncorus, Inc. | Oncolytic viral vectors and uses thereof |
| JP7557738B2 (ja) | 2018-10-30 | 2024-09-30 | 国立大学法人 東京大学 | がん治療のための腫瘍溶解性ウイルス |
| EP3941513A4 (en) | 2019-03-20 | 2023-01-11 | Turnstone Biologics Inc. | METHODS OF INDUCING AN IMMUNE RESPONSE AGAINST NEOANTIGENS |
| WO2020186355A1 (en) | 2019-03-20 | 2020-09-24 | Turnstone Biologics Inc. | Sequential heterologous boost oncolytic viral mmunotherapy |
| CN114765990A (zh) | 2019-10-10 | 2022-07-19 | 昂克诺斯公司 | 双重病毒和双重溶瘤病毒以及治疗方法 |
| JP2023502099A (ja) | 2019-11-18 | 2023-01-20 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド | コドン最適化された新世代の調節可能な融合性腫瘍溶解性単純ヘルペスウイルス１型ウイルスおよび使用方法 |
-
2018
- 2018-07-26 US US16/633,653 patent/US11612625B2/en active Active
- 2018-07-26 CA CA3070299A patent/CA3070299A1/en active Pending
- 2018-07-26 SG SG11202000691XA patent/SG11202000691XA/en unknown
- 2018-07-26 CN CN201880057565.XA patent/CN111212656B/zh active Active
- 2018-07-26 AU AU2018306455A patent/AU2018306455A1/en not_active Abandoned
- 2018-07-26 KR KR1020207005429A patent/KR20200042904A/ko not_active Ceased
- 2018-07-26 EP EP18837388.0A patent/EP3658165A4/en active Pending
- 2018-07-26 WO PCT/US2018/043938 patent/WO2019023483A1/en not_active Ceased
- 2018-07-26 MX MX2020000993A patent/MX2020000993A/es unknown
- 2018-07-26 RU RU2020108004A patent/RU2771110C2/ru active
- 2018-07-26 JP JP2020504236A patent/JP7249323B2/ja active Active
- 2018-07-26 BR BR112020001559-8A patent/BR112020001559A2/pt not_active IP Right Cessation
-
2020
- 2020-01-12 IL IL271993A patent/IL271993A/en unknown
-
2023
- 2023-02-07 US US18/165,770 patent/US12208126B2/en active Active
- 2023-03-17 JP JP2023043321A patent/JP7652823B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020532951A5 (enExample) | ||
| RU2020108004A (ru) | Онколитические вирусные векторы и их применение | |
| US20230115116A1 (en) | Oncolytic viral vectors and uses thereof | |
| JP2019508063A5 (enExample) | ||
| JP2020530778A5 (enExample) | ||
| JP2021119797A5 (enExample) | ||
| RU2020106730A (ru) | Инкапсулированные полинуклеотиды и способы их применения | |
| Sanchala et al. | Oncolytic herpes simplex viral therapy: a stride toward selective targeting of cancer cells | |
| RU2016120618A (ru) | Онколитический hsv-вектор | |
| Grandi et al. | Design and application of oncolytic HSV vectors for glioblastoma therapy | |
| US20250049867A1 (en) | Engineered oncolytic herpesviruses | |
| Zhou et al. | oncolytic HSV-1 virus | |
| Todo et al. | Development of oncolytic replication-competent herpes simplex virus vectors: the G207 paradigm | |
| Buhrman et al. | ENGINEERING VIRUS FOR CANCER HERPES ONCOLYTIC SIMPLEX VIROTHERAPY |